Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastric or Gastroesophageal Junction Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07655661
What this trial is testing

Mannatide Combined With CAPOX and Tislelizumab for Advanced Gastric Cancer.

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Ming Liu 52
Not applicableLooking for participantsNCT04688801
What this trial is testing

Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer

Who this might be right for
Esophageal CancerGastroesophageal CancerImmunotherapy+1 more
The Second Hospital of Shandong University 200
Testing effectiveness (Phase 2)UnknownNCT03990103
What this trial is testing

S1+ Paclitaxel (IV&IP) + Bevacizumab (IP) Versus S1+Oxaliplatin as First-line Treatment in Gastric Cancer With Malignant Ascites

Who this might be right for
Metastatic Gastric Adenocarcinoma
China Medical University, China 66
Testing effectiveness (Phase 2)Looking for participantsNCT06776770
What this trial is testing

A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer

Who this might be right for
Gastric Cancer
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center 52
Large-scale testing (Phase 3)Active Not RecruitingNCT04950322
What this trial is testing

A Trial of SHR1701 Plus Chemotherapy in Patients With Gastric or Gastroesophageal Cancer

Who this might be right for
Gastric or Gastroesophageal Junction Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 737
Testing effectiveness (Phase 2)Study completedNCT00022139
What this trial is testing

Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Who this might be right for
Esophageal CancerGastric Cancer
Alliance for Clinical Trials in Oncology 56
Early research (Phase 1)Active Not RecruitingNCT04460937
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers

Who this might be right for
Clinical Stage III Esophageal Adenocarcinoma AJCC v8Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8+56 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT04225117
What this trial is testing

Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)

Who this might be right for
Locally Advanced or Metastatic Malignant Solid Tumors
Astellas Pharma Global Development, Inc. 329
Not applicableStudy completedNCT05892926
What this trial is testing

HER2-positive Locally Advanced/Metastatic Gastric and/or Gastroesophageal Junction (GEJ) Adenocarcinoma in Russia

Who this might be right for
Adenocarcinoma
AstraZeneca 204
Testing effectiveness (Phase 2)Looking for participantsNCT07025889
What this trial is testing

IBI343 Combined With Sintilimab Plus Chemotherapy in Gastric Cancer

Who this might be right for
Gastric Cancer
Ruijin Hospital 55
Testing effectiveness (Phase 2)Study completedNCT02730546
What this trial is testing

Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery

Who this might be right for
Gastric Cardia AdenocarcinomaGastroesophageal Junction AdenocarcinomaStage IB Gastric Cancer AJCC v7+5 more
Mayo Clinic 31
Large-scale testing (Phase 3)Not Yet RecruitingNCT06944496
What this trial is testing

Disitamab Vedotin Combined With Tislelizumab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in HER2-Low Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Carcinoma
RemeGen Co., Ltd. 616
Early research (Phase 1)Enrolling By InvitationNCT07218003
What this trial is testing

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

Who this might be right for
Non Small Cell Lung CancerCervical CancerHead and Neck Squamous Cell Cancer+7 more
Rondo Therapeutics 149
Testing effectiveness (Phase 2)Study completedNCT01472029
What this trial is testing

Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or Stomach

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionAdenocarcinoma of the Stomach
AIO-Studien-gGmbH 53
Testing effectiveness (Phase 2)Ended earlyNCT05311176
What this trial is testing

IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON)

Who this might be right for
Gastric CancerCancer of StomachGastric Adenocarcinoma+3 more
Imugene Limited 7
Post-approval studies (Phase 4)Not Yet RecruitingNCT07801027
What this trial is testing

A Trial of Pembrolizumab With Chemotherapy or Chemoradiotherapy in Participants From India With Different Types of Cancer (MK-3475-G44/KEYNOTE-G44)

Who this might be right for
Neoplasm MalignantGastric NeoplasmsGastroesophageal Junction Adenocarcinoma+2 more
Merck Sharp & Dohme LLC 150
Testing effectiveness (Phase 2)Study completedNCT01630083
What this trial is testing

Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric Cancer

Who this might be right for
CLDN18.2-positive Adenocarcinoma of the Gastroesophageal JunctionCLDN18.2-positive Adenocarcinoma of EsophagusCLDN18.2-positive Gastric Adenocarcinoma
Astellas Pharma Global Development, Inc. 252
Testing effectiveness (Phase 2)UnknownNCT04792515
What this trial is testing

Camrelizumab Combined With SOX and/or Apatinib for Locally Advanced Gastric Cancer

Who this might be right for
Locally Advanced Gastric Cancer
First Affiliated Hospital Xi'an Jiaotong University 67
Testing effectiveness (Phase 2)UnknownNCT02525237
What this trial is testing

Apatinib in Combination With S-1 as First-Line Treatment in Patients With Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Qingdao Municipal Hospital 30
Testing effectiveness (Phase 2)WithdrawnNCT00620607
What this trial is testing

HuC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas

Who this might be right for
Stomach NeoplasmsMetastatic or Locally Advanced Gastric CancerMetastatic or Local Advanced GE Junction Cancer
ImmunoGen, Inc.
Next Page
4